Vanda Ruling Opens Door For Contesting FDA Drug Denials

By Chad Landmon, Claire Davies and Suzanne Bassett ( September 24, 2025, 6:17 PM EDT) -- Since the U.S. Supreme Court's Loper Bright decision last year, one question that is often asked is whether companies will more aggressively challenge U.S. Food and Drug Administration product approval denials in court....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login